EDITORIAL
Published on 29 Jun 2021
Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
doi 10.3389/fendo.2021.719647
- 2,628 views
- 1 citation
- Frontiers in Endocrinology
- Reproduction
- Research Topics
- POSEIDON’s Stratification of "Low Prognosis Patients in ART": The WHY, the WHAT, and the HOW
POSEIDON’s Stratification of "Low Prognosis Patients in ART": The WHY, the WHAT, and the HOW
42k
Total Downloads
196k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
POLICY AND PRACTICE REVIEWS
Published on 19 Mar 2021
Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
doi 10.3389/fendo.2021.587051
- 4,994 views
- 21 citations
ORIGINAL RESEARCH
Published on 12 Mar 2021
Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
doi 10.3389/fendo.2021.630550
- 5,354 views
- 19 citations
GENERAL COMMENTARY
Published on 27 Nov 2020
Response: Commentary: A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing In Vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
doi 10.3389/fendo.2020.598416
- 1,338 views
GENERAL COMMENTARY
Published on 02 Sep 2020
Commentary: A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator
doi 10.3389/fendo.2020.00618
- 1,218 views
- 2 citations
PERSPECTIVE
Published on 27 Feb 2020
Management Strategies for POSEIDON Group 2
doi 10.3389/fendo.2020.00105
- 4,636 views
- 10 citations
GENERAL COMMENTARY
Published on 04 Feb 2020
Commentary: Management Strategies for POSEIDON Groups 3 and 4
doi 10.3389/fendo.2020.00034
- 1,666 views
- 4 citations
GENERAL COMMENTARY
Published on 24 Jan 2020
Commentary: Management Strategies for POSEIDON Groups 3 and 4
doi 10.3389/fendo.2019.00920
- 2,049 views
- 3 citations
ORIGINAL RESEARCH
Published on 24 Jan 2020
Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection
doi 10.3389/fendo.2019.00917
- 9,531 views
- 36 citations
PERSPECTIVE
Published on 20 Nov 2019
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
doi 10.3389/fendo.2019.00814
- 35,557 views
- 84 citations
OPINION
Published on 01 Oct 2019
Management Strategies for POSEIDON's Group 1
doi 10.3389/fendo.2019.00679
- 4,275 views
- 19 citations
REVIEW
Published on 11 Sep 2019
Management Strategies for POSEIDON Groups 3 and 4
doi 10.3389/fendo.2019.00614
- 12,233 views
- 54 citations
Published in
Frontiers in Endocrinology
- Reproduction
Participating Journals
Frontiers in Physiology
ReproductionOffline
- 3.2 impact factor
- 6.5 citescore
Impact
- 196kTopic views
- 148kArticle views
- 42kArticle downloads